Primary and secondary paediatric hypertension.
High blood pressure (BP) or hypertension is a well known risk factor for developing heart attack, stroke, atrial fibrillation and renal failure. Although in the past hypertension was suppose...
Atrial Fibrillation
Authoritative medical articles, news, research, and guidelines pertaining to Atrial Fibrillation.
Advances in Clinical Cardiology 2022: A Summary of Key Clinical Trials.
Over the course of 2022, numerous key clinical trials with valuable contributions to clinical cardiology were published or presented at major international conferences. This review seeks to ...
Diagnostic accuracy of an oscillometric blood pressure monitor for atrial fibrillation screening.
Atrial fibrillation is the most common arrhythmia of clinical significance and hypertension is one of its major risk factors. This study aimed to evaluate the diagnostic accuracy of an autom...
Development and Feasibility of a Primary Care Provider Training Intervention to Improve Atrial Fibrillation Management.
Disparities in atrial fibrillation (AF) care are partially attributed to inadequate access to providers with specialized training in AF. Primary care providers (PCPs) are often the sole prov...
Sociodemographic determinants of oral anticoagulant prescription in patients with atrial fibrillations: findings from the PINNACLE registry using machine learning.
Current risk scores that are solely based on clinical factors have shown modest predictive ability for understanding of factors associated with gaps in real-world prescription of oral antico...
A Survey of Saudi General Practitioners on the Use of Thromboprophylaxis Guidelines and Risk Assessment Tools in Atrial Fibrillation.
Clinical practice guidelines advise patients with atrial fibrillation who are at risk for stroke to undergo thromboprophylaxis with oral anticoagulants. However, it is noted that guidelines ...
Real-World Evaluation of Anticoagulant Treatment Patterns in Patients with Atrial Fibrillation: Data from Multicenter ROTA Study.
Oral anticoagulant therapy is the cornerstone of atrial fibrillation management to prevent stroke and systemic embolism. However, there is limited real-world information regarding stroke an...
Twenty-year experience of atrial fibrillation ablation: a single-centre cohort study.
While several studies in the literature have reported results of catheter ablation of AF, few is known regarding outcome for more than 10 years.The complete population of patients who underw...
The predictive value of precipitating factors on clinical outcomes in hospitalized patients with decompensated heart failure: insights from the Egyptian cohort in the European Society of Cardiology Heart Failure long-term registry.
Knowledge of the frequency of precipitating factors for acute heart failure (AHF) is important (either new-onset heart failure [NOHF] or worsening heart failure [WHF]), as this can guide str...
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy.
High platelet reactivity (HPR) on clopidogrel is an established thrombotic risk factor after percutaneous coronary intervention (PCI). The introduction of more potent antiplatelet drugs has ...
Clinical Validation of 5 Direct-to-Consumer Wearable Smart Devices to Detect Atrial Fibrillation: BASEL Wearable Study.
Multiple smart devices capable to detect atrial fibrillation (AF) are presently available. Sensitivity and specificity for the detection of AF may differ between available smart devices, and...
Atrial fibrillation classification based on the 2D representation of minimal subset ECG and a non-deep neural network.
Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its early detection is critical for preventing complications and optimizing treatment. In this study, a novel AF predictio...
Clinical significance of the rivaroxaban-dronedarone interaction: insights from physiologically based pharmacokinetic modelling.
Patients with atrial fibrillation may require rhythm control therapy in addition to anticoagulation therapy for the prevention of stroke. Since 2012, the European Society of Cardiology and E...
Omega-3 fatty acids in heart disease-why accurately measured levels matter.
Current guidelines barely support marine omega‑3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in cardiology, mainly because results of large trials were equivocal...
Relationship Between Atrial Fibrillation and Controlling Nutritional Status Score in Acute Ischemic Stroke Patients.
To determine the relationship between nutritional status evaluated via the COntrolling NUTritional Status (CONUT) score and in-hospital mortality in acute ischemic stroke (AIS) patients.Obse...
Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke.
Atrial fibrillation (AF) underlies almost one third of all ischaemic strokes, with the left atrial appendage (LAA) identified as the primary thromboembolic source. Current stroke risk strati...
[ANMCO-SIMEU Consensus document: Appropriate management of atrial fibrillation in the emergency department].
Atrial fibrillation (AF) accounts for 2% of the total presentations to the emergency department (ED) and represents the most frequent arrhythmic cause for hospitalization. It steadily increa...
#VisualAbstract: Catheter ablation reduces rates of persistent atrial fibrillation and atrial tachyarrhythmia
1. In patients with untreated paroxysmal atrial fibrillation, catheter ablation was associated with reduced rates of persistent atrial fibrillation and tachyarrhythmias compared to pharm...
Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the US.
Insertable cardiac monitors (ICMs) are a clinically effective means of detecting atrial fibrillation (AF) in high-risk patients, and guiding the initiation of non-vitamin K oral anticoagulan...
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases.
Increasing rates of obesity and diabetes have driven corresponding increases in related cardiorenal and metabolic diseases. In many patients, these conditions occur together, further increas...
MORE ARTICLES BELOW 
PW Weekly Newsletters
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Advertisement
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.